Cargando…
β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis
Background: Evidence remains inconsistent regarding the potential influence of β-blocker (BB) use on clinical outcomes in women with breast cancer. We aimed to evaluate the association between BB and prognosis of breast cancer in an updated meta-analysis. Methods: Follow-up studies comparing the cli...
Autores principales: | Li, Chaoran, Li, Tian, Tang, Runwei, Yuan, Shuai, Zhang, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303345/ https://www.ncbi.nlm.nih.gov/pubmed/32436935 http://dx.doi.org/10.1042/BSR20200721 |
Ejemplares similares
-
Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
por: Zhou, Qianmei, et al.
Publicado: (2019) -
Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway
por: Wang, Wei, et al.
Publicado: (2019) -
Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis
por: Wei, Yuxia, et al.
Publicado: (2019) -
Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women
por: Ye, Dong‐Man, et al.
Publicado: (2019) -
Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
por: Lv, Peng, et al.
Publicado: (2020)